Richard Young

Richard Young began their career in 1984 as a Professor at Whitehead Institute and MIT, where they worked on mapping the regulatory circuitry that controls health and disease in human cells. In 2013, they founded and became the Director of Syros Pharmaceuticals. In 2016, they founded and became the Director of CAMP4 Therapeutics. In 2017, they founded and became the Director of Omega Therapeutics. In 2018, they founded and became the Director of Dewpoint Therapeutics.

Richard Young received their PhD in Molecular Biophysics and Biochemistry from Yale University between 1974 and 1979.